Medicure Inc (MCUJF) — SEC Filings

Medicure Inc (MCUJF) — 23 SEC filings. Latest: 6-K (Nov 19, 2025). Includes 21 6-K, 2 20-F.

View Medicure Inc on SEC EDGAR

Overview

Medicure Inc (MCUJF) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Nov 19, 2025: On November 19, 2025, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of November 2025 and indicates that MEDICURE INC. is a foreign private issuer filing under the 1934 Act. The company's principal executive offices are located at 2-1250 Waverley Street, Winnipeg, MB, Cana

Sentiment Summary

Across 23 filings, the sentiment breakdown is: 1 bullish, 22 neutral. The dominant filing sentiment for Medicure Inc is neutral.

Filing Type Overview

Medicure Inc (MCUJF) has filed 21 6-K, 2 20-F with the SEC between Apr 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent SEC Filings (23)

Medicure Inc SEC Filing History
DateFormDescriptionRisk
Nov 19, 20256-KMEDICURE INC. Files November 2025 6-K Reportlow
Nov 14, 20256-K6-K Filing
Aug 21, 20256-KMEDICURE INC. Files August 2025 6-K Reportlow
Jun 18, 20256-KMEDICURE INC. Files June 2025 6-K Reportlow
May 21, 20256-KMEDICURE INC. Q1 2025 Results: Revenue $33.78M, Net Loss $3.38Mmedium
Apr 28, 20256-KMEDICURE INC. Files Form 6-K with SEClow
Apr 25, 202520-FMEDICURE INC Files 2024 Annual Reportlow
Apr 23, 20256-KMEDICURE INC. Files Form 6-Klow
Apr 11, 20256-KMEDICURE INC. Files April 2025 6-K Reportlow
Mar 12, 20256-KMEDICURE INC. Files March 2025 6-K Reportlow
Feb 18, 20256-KMEDICURE INC. Files February 2025 6-K Reportlow
Nov 26, 20246-KMEDICURE INC. Files November 2024 6-K Reportlow
Nov 18, 20246-KMEDICURE INC. Files October 2024 6-K Reportlow
Oct 25, 20246-KMEDICURE INC. Files October 6-K Reportlow
Aug 26, 20246-KMEDICURE INC. Files August 2024 6-K Reportlow
Aug 15, 20246-KMEDICURE INC. Files August 2024 6-K Reportlow
Aug 14, 20246-KMEDICURE INC. Files August 2024 6-K Reportlow
Jun 25, 20246-KMedicure Inc. Signs New Agreement, Files 6-Klow
May 29, 20246-KMedicure Inc. Files 6-K with Financial Resultslow
Apr 26, 20246-KMedicure's MC-302 Gets FDA Fast Track for Psoriasismedium

Risk Profile

Risk Assessment: Of MCUJF's 22 recent filings, 0 were flagged as high-risk, 3 as medium-risk, and 19 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

  • Dr. Albert D. Friesen

Industry Context

MEDICURE INC. operates within the pharmaceutical preparations sector, a segment characterized by research and development, manufacturing, and distribution of medicinal products.

Top Tags

foreign-private-issuer (15) · reporting (7) · sec-filing (6) · 6-K (4) · regulatory-filing (3) · financial-results (3) · pharmaceuticals (2) · 6-k (2) · filing (2) · disclosure (1)

Key Numbers

Medicure Inc Key Metrics
MetricValueContext
SEC File Number001-31995Identifies the company's filing history with the SEC.
Report Date20250617The period the 6-K report covers.
Q1 2025 Revenue$33.78MRepresents the total sales for the first quarter of 2025.
Q1 2025 Net Loss$3.38MIndicates the company's profitability for the first quarter of 2025.
Public Documents109Number of documents included in the filing
Fiscal Year End2024-12-31The period covered by the annual report
Filing Date2024-04-09Date the 20-F report was filed
Public Document Count103Number of documents included in the filing

Related Companies

MCU · MCUR

Frequently Asked Questions

What are the latest SEC filings for Medicure Inc (MCUJF)?

Medicure Inc has 23 recent SEC filings from Apr 2024 to Nov 2025, including 21 6-K, 2 20-F. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of MCUJF filings?

Across 23 filings, the sentiment breakdown is: 1 bullish, 22 neutral. The dominant sentiment is neutral.

Where can I find Medicure Inc SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Medicure Inc (MCUJF) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Medicure Inc?

Financial highlights for Medicure Inc are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.

What is the investment thesis for MCUJF?

The investment thesis for MCUJF includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Medicure Inc?

Key executives identified across Medicure Inc's filings include Dr. Albert D. Friesen.

What are the main risk factors for Medicure Inc stock?

Of MCUJF's 22 assessed filings, 0 were flagged high-risk, 3 medium-risk, and 19 low-risk.

What are recent predictions and forward guidance from Medicure Inc?

Forward guidance and predictions for Medicure Inc are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.